Several biotechnology firms are moving toward synthetic production of THC, CBD and other cannabinoids in a lab, using ingredients such as sugar and yeast, which if successful, can potentially produce these active compounds more cheaply than traditional cultivation and extraction.
Meanwhile, although there is growing buzz around magic mushrooms and the medicinal applications of psilocybin and Canopy Rivers has received some pitches from companies in this space, Alexandrian believes it is too early for an investment. He says that, compared to cannabis, the stigma is larger and the number of people who have tried magic mushrooms is fewer, but Canopy Rivers is watching in case potential for medicinal psilocybin develops further.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Fonte: CTVNews - 🏆 1. / 99 Consulte Mais informação »
Fonte: CTVNews - 🏆 1. / 99 Consulte Mais informação »